nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP3A4—Everolimus—kidney cancer	0.0887	0.201	CbGbCtD
Aminophylline—CYP1A2—Pazopanib—kidney cancer	0.0601	0.136	CbGbCtD
Aminophylline—CYP3A4—Temsirolimus—kidney cancer	0.0599	0.136	CbGbCtD
Aminophylline—CYP1A2—Erlotinib—kidney cancer	0.0429	0.0972	CbGbCtD
Aminophylline—CYP1A2—Sorafenib—kidney cancer	0.0349	0.0791	CbGbCtD
Aminophylline—CYP3A4—Pazopanib—kidney cancer	0.0315	0.0714	CbGbCtD
Aminophylline—CYP3A4—Erlotinib—kidney cancer	0.0225	0.0509	CbGbCtD
Aminophylline—CYP3A4—Paclitaxel—kidney cancer	0.0206	0.0466	CbGbCtD
Aminophylline—CYP3A4—Sorafenib—kidney cancer	0.0183	0.0414	CbGbCtD
Aminophylline—CYP3A4—Vinblastine—kidney cancer	0.018	0.0409	CbGbCtD
Aminophylline—CYP3A4—Vincristine—kidney cancer	0.0177	0.0402	CbGbCtD
Aminophylline—CYP3A4—Sunitinib—kidney cancer	0.0148	0.0336	CbGbCtD
Aminophylline—CYP3A4—Doxorubicin—kidney cancer	0.0111	0.0251	CbGbCtD
Aminophylline—CYP1A2—urine—kidney cancer	0.0056	0.102	CbGeAlD
Aminophylline—CYP2E1—urine—kidney cancer	0.00504	0.0917	CbGeAlD
Aminophylline—CYP3A4—urine—kidney cancer	0.00405	0.0738	CbGeAlD
Aminophylline—HDAC2—nephron tubule—kidney cancer	0.00328	0.0597	CbGeAlD
Aminophylline—ADORA2A—gonad—kidney cancer	0.00313	0.057	CbGeAlD
Aminophylline—ADORA1—renal system—kidney cancer	0.00302	0.0549	CbGeAlD
Aminophylline—HDAC2—renal system—kidney cancer	0.00298	0.0542	CbGeAlD
Aminophylline—ADORA1—kidney—kidney cancer	0.00292	0.0531	CbGeAlD
Aminophylline—HDAC2—kidney—kidney cancer	0.00288	0.0524	CbGeAlD
Aminophylline—ADORA1—cortex of kidney—kidney cancer	0.00284	0.0517	CbGeAlD
Aminophylline—HDAC2—cortex of kidney—kidney cancer	0.0028	0.0511	CbGeAlD
Aminophylline—PDE3A—cardiac atrium—kidney cancer	0.00277	0.0505	CbGeAlD
Aminophylline—ADORA1—cardiac atrium—kidney cancer	0.0027	0.0492	CbGeAlD
Aminophylline—HDAC2—gonad—kidney cancer	0.00267	0.0486	CbGeAlD
Aminophylline—HDAC2—Sirolimus—Temsirolimus—kidney cancer	0.00208	0.2	CbGdCrCtD
Aminophylline—HDAC2—Temsirolimus—Everolimus—kidney cancer	0.00208	0.2	CbGdCrCtD
Aminophylline—HDAC2—Sirolimus—Everolimus—kidney cancer	0.00208	0.2	CbGdCrCtD
Aminophylline—HDAC2—Everolimus—Temsirolimus—kidney cancer	0.00208	0.2	CbGdCrCtD
Aminophylline—HDAC2—Gefitinib—Erlotinib—kidney cancer	0.00208	0.199	CbGdCrCtD
Aminophylline—CYP1A2—renal system—kidney cancer	0.00137	0.0249	CbGeAlD
Aminophylline—CYP2E1—nephron tubule—kidney cancer	0.00136	0.0247	CbGeAlD
Aminophylline—CYP2E1—renal system—kidney cancer	0.00123	0.0224	CbGeAlD
Aminophylline—CYP2E1—kidney—kidney cancer	0.00119	0.0217	CbGeAlD
Aminophylline—Theophylline—CYP1A1—kidney cancer	0.00117	1	CrCbGaD
Aminophylline—CYP2E1—cortex of kidney—kidney cancer	0.00116	0.0211	CbGeAlD
Aminophylline—CYP3A4—renal system—kidney cancer	0.000992	0.0181	CbGeAlD
Aminophylline—CYP3A4—kidney—kidney cancer	0.000959	0.0175	CbGeAlD
Aminophylline—Urinary retention—Capecitabine—kidney cancer	0.000606	0.00186	CcSEcCtD
Aminophylline—Hyperglycaemia—Paclitaxel—kidney cancer	0.000606	0.00186	CcSEcCtD
Aminophylline—Dizziness—Temsirolimus—kidney cancer	0.000605	0.00186	CcSEcCtD
Aminophylline—Convulsion—Sunitinib—kidney cancer	0.000604	0.00185	CcSEcCtD
Aminophylline—Dyspepsia—Everolimus—kidney cancer	0.000599	0.00184	CcSEcCtD
Aminophylline—Alopecia—Vincristine—kidney cancer	0.000598	0.00183	CcSEcCtD
Aminophylline—Insomnia—Erlotinib—kidney cancer	0.000594	0.00182	CcSEcCtD
Aminophylline—Decreased appetite—Vinblastine—kidney cancer	0.000594	0.00182	CcSEcCtD
Aminophylline—Decreased appetite—Everolimus—kidney cancer	0.000592	0.00182	CcSEcCtD
Aminophylline—Anaphylactic shock—Sorafenib—kidney cancer	0.000591	0.00181	CcSEcCtD
Aminophylline—Diarrhoea—Pazopanib—kidney cancer	0.00059	0.00181	CcSEcCtD
Aminophylline—Infection—Sorafenib—kidney cancer	0.000587	0.0018	CcSEcCtD
Aminophylline—Abdominal pain upper—Capecitabine—kidney cancer	0.000582	0.00179	CcSEcCtD
Aminophylline—Vomiting—Temsirolimus—kidney cancer	0.000582	0.00178	CcSEcCtD
Aminophylline—Shock—Sorafenib—kidney cancer	0.000581	0.00178	CcSEcCtD
Aminophylline—Hypokalaemia—Capecitabine—kidney cancer	0.00058	0.00178	CcSEcCtD
Aminophylline—Nervous system disorder—Sorafenib—kidney cancer	0.000579	0.00178	CcSEcCtD
Aminophylline—Dyspepsia—Erlotinib—kidney cancer	0.000578	0.00177	CcSEcCtD
Aminophylline—Rash—Temsirolimus—kidney cancer	0.000577	0.00177	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—kidney cancer	0.000577	0.00177	CcSEcCtD
Aminophylline—Dermatitis—Temsirolimus—kidney cancer	0.000576	0.00177	CcSEcCtD
Aminophylline—Arrhythmia—Gemcitabine—kidney cancer	0.000574	0.00176	CcSEcCtD
Aminophylline—Headache—Temsirolimus—kidney cancer	0.000573	0.00176	CcSEcCtD
Aminophylline—Haematuria—Paclitaxel—kidney cancer	0.000571	0.00175	CcSEcCtD
Aminophylline—Decreased appetite—Erlotinib—kidney cancer	0.000571	0.00175	CcSEcCtD
Aminophylline—Dizziness—Pazopanib—kidney cancer	0.00057	0.00175	CcSEcCtD
Aminophylline—Alopecia—Gemcitabine—kidney cancer	0.000567	0.00174	CcSEcCtD
Aminophylline—Infection—Sunitinib—kidney cancer	0.000565	0.00173	CcSEcCtD
Aminophylline—Anorexia—Sorafenib—kidney cancer	0.000563	0.00173	CcSEcCtD
Aminophylline—Dermatitis contact—Doxorubicin—kidney cancer	0.00056	0.00172	CcSEcCtD
Aminophylline—Shock—Sunitinib—kidney cancer	0.000559	0.00172	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vinblastine—kidney cancer	0.000559	0.00171	CcSEcCtD
Aminophylline—Nervous system disorder—Sunitinib—kidney cancer	0.000558	0.00171	CcSEcCtD
Aminophylline—Gastrointestinal pain—Everolimus—kidney cancer	0.000557	0.00171	CcSEcCtD
Aminophylline—Vomiting—Pazopanib—kidney cancer	0.000548	0.00168	CcSEcCtD
Aminophylline—Rash—Pazopanib—kidney cancer	0.000544	0.00167	CcSEcCtD
Aminophylline—Nausea—Temsirolimus—kidney cancer	0.000544	0.00167	CcSEcCtD
Aminophylline—Dermatitis—Pazopanib—kidney cancer	0.000543	0.00167	CcSEcCtD
Aminophylline—Anorexia—Sunitinib—kidney cancer	0.000542	0.00166	CcSEcCtD
Aminophylline—Agitation—Vincristine—kidney cancer	0.000542	0.00166	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—kidney cancer	0.000541	0.00166	CcSEcCtD
Aminophylline—Abdominal pain—Vinblastine—kidney cancer	0.00054	0.00166	CcSEcCtD
Aminophylline—Headache—Pazopanib—kidney cancer	0.00054	0.00166	CcSEcCtD
Aminophylline—Body temperature increased—Everolimus—kidney cancer	0.000538	0.00165	CcSEcCtD
Aminophylline—Abdominal pain—Everolimus—kidney cancer	0.000538	0.00165	CcSEcCtD
Aminophylline—Gastrointestinal pain—Erlotinib—kidney cancer	0.000537	0.00165	CcSEcCtD
Aminophylline—Infection—Dactinomycin—kidney cancer	0.000535	0.00164	CcSEcCtD
Aminophylline—Dyspepsia—Sorafenib—kidney cancer	0.00052	0.0016	CcSEcCtD
Aminophylline—Body temperature increased—Erlotinib—kidney cancer	0.000519	0.00159	CcSEcCtD
Aminophylline—Abdominal pain—Erlotinib—kidney cancer	0.000519	0.00159	CcSEcCtD
Aminophylline—Coma—Doxorubicin—kidney cancer	0.000517	0.00159	CcSEcCtD
Aminophylline—Insomnia—Sunitinib—kidney cancer	0.000514	0.00158	CcSEcCtD
Aminophylline—Decreased appetite—Sorafenib—kidney cancer	0.000514	0.00158	CcSEcCtD
Aminophylline—Anorexia—Dactinomycin—kidney cancer	0.000513	0.00157	CcSEcCtD
Aminophylline—Nausea—Pazopanib—kidney cancer	0.000512	0.00157	CcSEcCtD
Aminophylline—Convulsion—Vincristine—kidney cancer	0.000511	0.00157	CcSEcCtD
Aminophylline—Hypersensitivity—Vinblastine—kidney cancer	0.000503	0.00154	CcSEcCtD
Aminophylline—Hypersensitivity—Everolimus—kidney cancer	0.000502	0.00154	CcSEcCtD
Aminophylline—Dyspepsia—Sunitinib—kidney cancer	0.0005	0.00154	CcSEcCtD
Aminophylline—Flushing—Paclitaxel—kidney cancer	0.000499	0.00153	CcSEcCtD
Aminophylline—Hyperglycaemia—Capecitabine—kidney cancer	0.000497	0.00153	CcSEcCtD
Aminophylline—Decreased appetite—Sunitinib—kidney cancer	0.000494	0.00152	CcSEcCtD
Aminophylline—Gastrointestinal pain—Sorafenib—kidney cancer	0.000483	0.00148	CcSEcCtD
Aminophylline—Pruritus—Everolimus—kidney cancer	0.000482	0.00148	CcSEcCtD
Aminophylline—Anaphylactic shock—Vincristine—kidney cancer	0.000481	0.00148	CcSEcCtD
Aminophylline—Arrhythmia—Paclitaxel—kidney cancer	0.00048	0.00147	CcSEcCtD
Aminophylline—Infection—Vincristine—kidney cancer	0.000478	0.00147	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—kidney cancer	0.000477	0.00146	CcSEcCtD
Aminophylline—Alopecia—Paclitaxel—kidney cancer	0.000475	0.00146	CcSEcCtD
Aminophylline—Nervous system disorder—Vincristine—kidney cancer	0.000472	0.00145	CcSEcCtD
Aminophylline—Urticaria—Sorafenib—kidney cancer	0.000469	0.00144	CcSEcCtD
Aminophylline—Haematuria—Capecitabine—kidney cancer	0.000469	0.00144	CcSEcCtD
Aminophylline—Decreased appetite—Dactinomycin—kidney cancer	0.000468	0.00144	CcSEcCtD
Aminophylline—Diarrhoea—Vinblastine—kidney cancer	0.000468	0.00143	CcSEcCtD
Aminophylline—Body temperature increased—Sorafenib—kidney cancer	0.000467	0.00143	CcSEcCtD
Aminophylline—Abdominal pain—Sorafenib—kidney cancer	0.000467	0.00143	CcSEcCtD
Aminophylline—Diarrhoea—Everolimus—kidney cancer	0.000466	0.00143	CcSEcCtD
Aminophylline—Gastrointestinal pain—Sunitinib—kidney cancer	0.000465	0.00143	CcSEcCtD
Aminophylline—Pruritus—Erlotinib—kidney cancer	0.000465	0.00143	CcSEcCtD
Aminophylline—Tension—Paclitaxel—kidney cancer	0.000459	0.00141	CcSEcCtD
Aminophylline—Anorexia—Vincristine—kidney cancer	0.000458	0.00141	CcSEcCtD
Aminophylline—Anaphylactic shock—Gemcitabine—kidney cancer	0.000456	0.0014	CcSEcCtD
Aminophylline—Nervousness—Paclitaxel—kidney cancer	0.000455	0.00139	CcSEcCtD
Aminophylline—Infection—Gemcitabine—kidney cancer	0.000453	0.00139	CcSEcCtD
Aminophylline—Dizziness—Vinblastine—kidney cancer	0.000452	0.00139	CcSEcCtD
Aminophylline—Dizziness—Everolimus—kidney cancer	0.00045	0.00138	CcSEcCtD
Aminophylline—Body temperature increased—Sunitinib—kidney cancer	0.000449	0.00138	CcSEcCtD
Aminophylline—Abdominal pain—Sunitinib—kidney cancer	0.000449	0.00138	CcSEcCtD
Aminophylline—Diarrhoea—Erlotinib—kidney cancer	0.000449	0.00138	CcSEcCtD
Aminophylline—Hypotension—Vincristine—kidney cancer	0.000449	0.00138	CcSEcCtD
Aminophylline—Nervous system disorder—Gemcitabine—kidney cancer	0.000447	0.00137	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00044	0.00135	CcSEcCtD
Aminophylline—Tremor—Paclitaxel—kidney cancer	0.000438	0.00134	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000436	0.00134	CcSEcCtD
Aminophylline—Hypersensitivity—Sorafenib—kidney cancer	0.000435	0.00134	CcSEcCtD
Aminophylline—Insomnia—Vincristine—kidney cancer	0.000435	0.00133	CcSEcCtD
Aminophylline—Anorexia—Gemcitabine—kidney cancer	0.000435	0.00133	CcSEcCtD
Aminophylline—Vomiting—Vinblastine—kidney cancer	0.000434	0.00133	CcSEcCtD
Aminophylline—Dizziness—Erlotinib—kidney cancer	0.000434	0.00133	CcSEcCtD
Aminophylline—Vomiting—Everolimus—kidney cancer	0.000433	0.00133	CcSEcCtD
Aminophylline—Agitation—Paclitaxel—kidney cancer	0.00043	0.00132	CcSEcCtD
Aminophylline—Rash—Everolimus—kidney cancer	0.000429	0.00132	CcSEcCtD
Aminophylline—Dermatitis—Everolimus—kidney cancer	0.000429	0.00132	CcSEcCtD
Aminophylline—Headache—Vinblastine—kidney cancer	0.000428	0.00131	CcSEcCtD
Aminophylline—Headache—Everolimus—kidney cancer	0.000426	0.00131	CcSEcCtD
Aminophylline—Hypotension—Gemcitabine—kidney cancer	0.000426	0.00131	CcSEcCtD
Aminophylline—Body temperature increased—Dactinomycin—kidney cancer	0.000426	0.00131	CcSEcCtD
Aminophylline—Abdominal pain—Dactinomycin—kidney cancer	0.000426	0.00131	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000425	0.0013	CcSEcCtD
Aminophylline—Hypersensitivity—Sunitinib—kidney cancer	0.000419	0.00128	CcSEcCtD
Aminophylline—Decreased appetite—Vincristine—kidney cancer	0.000418	0.00128	CcSEcCtD
Aminophylline—Pruritus—Sorafenib—kidney cancer	0.000418	0.00128	CcSEcCtD
Aminophylline—Vomiting—Erlotinib—kidney cancer	0.000418	0.00128	CcSEcCtD
Aminophylline—Rash—Erlotinib—kidney cancer	0.000414	0.00127	CcSEcCtD
Aminophylline—Dermatitis—Erlotinib—kidney cancer	0.000414	0.00127	CcSEcCtD
Aminophylline—Palpitations—Paclitaxel—kidney cancer	0.000414	0.00127	CcSEcCtD
Aminophylline—Insomnia—Gemcitabine—kidney cancer	0.000413	0.00127	CcSEcCtD
Aminophylline—Headache—Erlotinib—kidney cancer	0.000411	0.00126	CcSEcCtD
Aminophylline—Flushing—Capecitabine—kidney cancer	0.000409	0.00126	CcSEcCtD
Aminophylline—Nausea—Vinblastine—kidney cancer	0.000406	0.00124	CcSEcCtD
Aminophylline—Convulsion—Paclitaxel—kidney cancer	0.000406	0.00124	CcSEcCtD
Aminophylline—Nausea—Everolimus—kidney cancer	0.000404	0.00124	CcSEcCtD
Aminophylline—Diarrhoea—Sorafenib—kidney cancer	0.000404	0.00124	CcSEcCtD
Aminophylline—Pruritus—Sunitinib—kidney cancer	0.000402	0.00123	CcSEcCtD
Aminophylline—Anxiety—Paclitaxel—kidney cancer	0.000397	0.00122	CcSEcCtD
Aminophylline—Decreased appetite—Gemcitabine—kidney cancer	0.000397	0.00122	CcSEcCtD
Aminophylline—Hypersensitivity—Dactinomycin—kidney cancer	0.000397	0.00122	CcSEcCtD
Aminophylline—Arrhythmia—Capecitabine—kidney cancer	0.000394	0.00121	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vincristine—kidney cancer	0.000393	0.00121	CcSEcCtD
Aminophylline—Dizziness—Sorafenib—kidney cancer	0.000391	0.0012	CcSEcCtD
Aminophylline—Nausea—Erlotinib—kidney cancer	0.00039	0.0012	CcSEcCtD
Aminophylline—Alopecia—Capecitabine—kidney cancer	0.00039	0.0012	CcSEcCtD
Aminophylline—Diarrhoea—Sunitinib—kidney cancer	0.000389	0.00119	CcSEcCtD
Aminophylline—Anaphylactic shock—Paclitaxel—kidney cancer	0.000382	0.00117	CcSEcCtD
Aminophylline—Abdominal pain—Vincristine—kidney cancer	0.00038	0.00117	CcSEcCtD
Aminophylline—Body temperature increased—Vincristine—kidney cancer	0.00038	0.00117	CcSEcCtD
Aminophylline—Infection—Paclitaxel—kidney cancer	0.000379	0.00116	CcSEcCtD
Aminophylline—Dizziness—Sunitinib—kidney cancer	0.000376	0.00115	CcSEcCtD
Aminophylline—Shock—Paclitaxel—kidney cancer	0.000376	0.00115	CcSEcCtD
Aminophylline—Vomiting—Sorafenib—kidney cancer	0.000376	0.00115	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—kidney cancer	0.000375	0.00115	CcSEcCtD
Aminophylline—Nervous system disorder—Paclitaxel—kidney cancer	0.000375	0.00115	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—kidney cancer	0.000374	0.00115	CcSEcCtD
Aminophylline—Tachycardia—Paclitaxel—kidney cancer	0.000373	0.00114	CcSEcCtD
Aminophylline—Rash—Sorafenib—kidney cancer	0.000373	0.00114	CcSEcCtD
Aminophylline—Dermatitis—Sorafenib—kidney cancer	0.000372	0.00114	CcSEcCtD
Aminophylline—Headache—Sorafenib—kidney cancer	0.00037	0.00114	CcSEcCtD
Aminophylline—Diarrhoea—Dactinomycin—kidney cancer	0.000368	0.00113	CcSEcCtD
Aminophylline—Anorexia—Paclitaxel—kidney cancer	0.000364	0.00112	CcSEcCtD
Aminophylline—Vomiting—Sunitinib—kidney cancer	0.000362	0.00111	CcSEcCtD
Aminophylline—Body temperature increased—Gemcitabine—kidney cancer	0.000361	0.00111	CcSEcCtD
Aminophylline—Tremor—Capecitabine—kidney cancer	0.00036	0.0011	CcSEcCtD
Aminophylline—Rash—Sunitinib—kidney cancer	0.000358	0.0011	CcSEcCtD
Aminophylline—Dermatitis—Sunitinib—kidney cancer	0.000358	0.0011	CcSEcCtD
Aminophylline—Hypotension—Paclitaxel—kidney cancer	0.000357	0.00109	CcSEcCtD
Aminophylline—Headache—Sunitinib—kidney cancer	0.000356	0.00109	CcSEcCtD
Aminophylline—Hypersensitivity—Vincristine—kidney cancer	0.000354	0.00109	CcSEcCtD
Aminophylline—Nausea—Sorafenib—kidney cancer	0.000351	0.00108	CcSEcCtD
Aminophylline—Insomnia—Paclitaxel—kidney cancer	0.000345	0.00106	CcSEcCtD
Aminophylline—Vomiting—Dactinomycin—kidney cancer	0.000342	0.00105	CcSEcCtD
Aminophylline—Palpitations—Capecitabine—kidney cancer	0.000339	0.00104	CcSEcCtD
Aminophylline—Rash—Dactinomycin—kidney cancer	0.000339	0.00104	CcSEcCtD
Aminophylline—Nausea—Sunitinib—kidney cancer	0.000338	0.00104	CcSEcCtD
Aminophylline—Dyspepsia—Paclitaxel—kidney cancer	0.000336	0.00103	CcSEcCtD
Aminophylline—Decreased appetite—Paclitaxel—kidney cancer	0.000332	0.00102	CcSEcCtD
Aminophylline—Diarrhoea—Vincristine—kidney cancer	0.000329	0.00101	CcSEcCtD
Aminophylline—Anxiety—Capecitabine—kidney cancer	0.000326	0.000999	CcSEcCtD
Aminophylline—Pruritus—Gemcitabine—kidney cancer	0.000323	0.00099	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—kidney cancer	0.000321	0.000983	CcSEcCtD
Aminophylline—Nausea—Dactinomycin—kidney cancer	0.00032	0.000981	CcSEcCtD
Aminophylline—Dizziness—Vincristine—kidney cancer	0.000318	0.000975	CcSEcCtD
Aminophylline—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000312	0.000958	CcSEcCtD
Aminophylline—Diarrhoea—Gemcitabine—kidney cancer	0.000312	0.000957	CcSEcCtD
Aminophylline—Infection—Capecitabine—kidney cancer	0.000311	0.000955	CcSEcCtD
Aminophylline—Shock—Capecitabine—kidney cancer	0.000308	0.000946	CcSEcCtD
Aminophylline—Nervous system disorder—Capecitabine—kidney cancer	0.000307	0.000943	CcSEcCtD
Aminophylline—Tachycardia—Capecitabine—kidney cancer	0.000306	0.000938	CcSEcCtD
Aminophylline—Vomiting—Vincristine—kidney cancer	0.000306	0.000938	CcSEcCtD
Aminophylline—Urticaria—Paclitaxel—kidney cancer	0.000303	0.000931	CcSEcCtD
Aminophylline—Rash—Vincristine—kidney cancer	0.000303	0.00093	CcSEcCtD
Aminophylline—Dermatitis—Vincristine—kidney cancer	0.000303	0.000929	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—kidney cancer	0.000302	0.000927	CcSEcCtD
Aminophylline—Abdominal pain—Paclitaxel—kidney cancer	0.000302	0.000926	CcSEcCtD
Aminophylline—Body temperature increased—Paclitaxel—kidney cancer	0.000302	0.000926	CcSEcCtD
Aminophylline—Headache—Vincristine—kidney cancer	0.000301	0.000924	CcSEcCtD
Aminophylline—Anorexia—Capecitabine—kidney cancer	0.000299	0.000916	CcSEcCtD
Aminophylline—Hypotension—Capecitabine—kidney cancer	0.000293	0.000898	CcSEcCtD
Aminophylline—Vomiting—Gemcitabine—kidney cancer	0.00029	0.00089	CcSEcCtD
Aminophylline—Rash—Gemcitabine—kidney cancer	0.000288	0.000882	CcSEcCtD
Aminophylline—Dermatitis—Gemcitabine—kidney cancer	0.000287	0.000881	CcSEcCtD
Aminophylline—Headache—Gemcitabine—kidney cancer	0.000286	0.000877	CcSEcCtD
Aminophylline—Nausea—Vincristine—kidney cancer	0.000286	0.000876	CcSEcCtD
Aminophylline—Insomnia—Capecitabine—kidney cancer	0.000284	0.00087	CcSEcCtD
Aminophylline—Hypersensitivity—Paclitaxel—kidney cancer	0.000281	0.000863	CcSEcCtD
Aminophylline—Dyspepsia—Capecitabine—kidney cancer	0.000276	0.000846	CcSEcCtD
Aminophylline—Decreased appetite—Capecitabine—kidney cancer	0.000272	0.000836	CcSEcCtD
Aminophylline—Nausea—Gemcitabine—kidney cancer	0.000271	0.000831	CcSEcCtD
Aminophylline—Pruritus—Paclitaxel—kidney cancer	0.00027	0.000829	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—kidney cancer	0.000264	0.00081	CcSEcCtD
Aminophylline—Diarrhoea—Paclitaxel—kidney cancer	0.000261	0.000802	CcSEcCtD
Aminophylline—Gastrointestinal pain—Capecitabine—kidney cancer	0.000256	0.000786	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—kidney cancer	0.000254	0.000779	CcSEcCtD
Aminophylline—Dizziness—Paclitaxel—kidney cancer	0.000253	0.000775	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—kidney cancer	0.000251	0.000771	CcSEcCtD
Aminophylline—Urticaria—Capecitabine—kidney cancer	0.000249	0.000764	CcSEcCtD
Aminophylline—Abdominal pain—Capecitabine—kidney cancer	0.000248	0.00076	CcSEcCtD
Aminophylline—Body temperature increased—Capecitabine—kidney cancer	0.000248	0.00076	CcSEcCtD
Aminophylline—Tension—Doxorubicin—kidney cancer	0.000243	0.000745	CcSEcCtD
Aminophylline—Vomiting—Paclitaxel—kidney cancer	0.000243	0.000745	CcSEcCtD
Aminophylline—Rash—Paclitaxel—kidney cancer	0.000241	0.000739	CcSEcCtD
Aminophylline—Dermatitis—Paclitaxel—kidney cancer	0.000241	0.000738	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—kidney cancer	0.00024	0.000738	CcSEcCtD
Aminophylline—Headache—Paclitaxel—kidney cancer	0.000239	0.000734	CcSEcCtD
Aminophylline—Hypersensitivity—Capecitabine—kidney cancer	0.000231	0.000708	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—kidney cancer	0.000228	0.000698	CcSEcCtD
Aminophylline—Nausea—Paclitaxel—kidney cancer	0.000227	0.000696	CcSEcCtD
Aminophylline—Pruritus—Capecitabine—kidney cancer	0.000222	0.00068	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—kidney cancer	0.000219	0.000671	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—kidney cancer	0.000215	0.000658	CcSEcCtD
Aminophylline—Diarrhoea—Capecitabine—kidney cancer	0.000214	0.000658	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—kidney cancer	0.00021	0.000644	CcSEcCtD
Aminophylline—Dizziness—Capecitabine—kidney cancer	0.000207	0.000636	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—kidney cancer	0.000202	0.00062	CcSEcCtD
Aminophylline—Infection—Doxorubicin—kidney cancer	0.000201	0.000616	CcSEcCtD
Aminophylline—Vomiting—Capecitabine—kidney cancer	0.000199	0.000611	CcSEcCtD
Aminophylline—Shock—Doxorubicin—kidney cancer	0.000199	0.00061	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—kidney cancer	0.000198	0.000608	CcSEcCtD
Aminophylline—Rash—Capecitabine—kidney cancer	0.000198	0.000606	CcSEcCtD
Aminophylline—Dermatitis—Capecitabine—kidney cancer	0.000197	0.000606	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—kidney cancer	0.000197	0.000605	CcSEcCtD
Aminophylline—Headache—Capecitabine—kidney cancer	0.000196	0.000602	CcSEcCtD
Aminophylline—Anorexia—Doxorubicin—kidney cancer	0.000193	0.000591	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—kidney cancer	0.000189	0.000579	CcSEcCtD
Aminophylline—Nausea—Capecitabine—kidney cancer	0.000186	0.000571	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—kidney cancer	0.000183	0.000561	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—kidney cancer	0.000178	0.000546	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—kidney cancer	0.000176	0.000539	CcSEcCtD
Aminophylline—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000165	0.000507	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—kidney cancer	0.000161	0.000492	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—kidney cancer	0.00016	0.00049	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—kidney cancer	0.00016	0.00049	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—kidney cancer	0.000149	0.000457	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—kidney cancer	0.000143	0.000438	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—kidney cancer	0.000138	0.000424	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—kidney cancer	0.000134	0.00041	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—kidney cancer	0.000128	0.000394	CcSEcCtD
Aminophylline—Rash—Doxorubicin—kidney cancer	0.000127	0.000391	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—kidney cancer	0.000127	0.00039	CcSEcCtD
Aminophylline—Headache—Doxorubicin—kidney cancer	0.000127	0.000388	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—kidney cancer	0.00012	0.000368	CcSEcCtD
Aminophylline—CYP2E1—Metabolism—CRABP1—kidney cancer	3.59e-05	0.000216	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.58e-05	0.000215	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KIT—kidney cancer	3.51e-05	0.000211	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—APC—kidney cancer	3.51e-05	0.000211	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CCBL1—kidney cancer	3.5e-05	0.000211	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—RAF1—kidney cancer	3.46e-05	0.000208	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—PIK3CA—kidney cancer	3.46e-05	0.000208	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	3.45e-05	0.000207	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GPC3—kidney cancer	3.44e-05	0.000207	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—POMC—kidney cancer	3.43e-05	0.000206	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—IL2—kidney cancer	3.42e-05	0.000205	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—KRAS—kidney cancer	3.42e-05	0.000205	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—BRAF—kidney cancer	3.39e-05	0.000204	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—APC—kidney cancer	3.37e-05	0.000203	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KIT—kidney cancer	3.37e-05	0.000203	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—MAPK3—kidney cancer	3.36e-05	0.000202	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CA2—kidney cancer	3.35e-05	0.000201	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—POMC—kidney cancer	3.34e-05	0.0002	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ITPR2—kidney cancer	3.34e-05	0.0002	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—BRAF—kidney cancer	3.3e-05	0.000198	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	3.28e-05	0.000197	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALAD—kidney cancer	3.26e-05	0.000196	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—MAPK3—kidney cancer	3.23e-05	0.000194	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—POMC—kidney cancer	3.21e-05	0.000193	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—MAPK1—kidney cancer	3.19e-05	0.000192	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.18e-05	0.000191	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—HIF1A—kidney cancer	3.18e-05	0.000191	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TSC2—kidney cancer	3.17e-05	0.000191	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—BRAF—kidney cancer	3.17e-05	0.000191	CbGpPWpGaD
Aminophylline—HDAC2—Disease—RAF1—kidney cancer	3.14e-05	0.000189	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—PIK3CA—kidney cancer	3.14e-05	0.000189	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	3.14e-05	0.000189	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—RAF1—kidney cancer	3.12e-05	0.000187	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.11e-05	0.000187	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ERBB2—kidney cancer	3.11e-05	0.000187	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL2—kidney cancer	3.1e-05	0.000186	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—KRAS—kidney cancer	3.1e-05	0.000186	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—RELA—kidney cancer	3.1e-05	0.000186	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ERBB2—kidney cancer	3.08e-05	0.000185	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—MAPK1—kidney cancer	3.08e-05	0.000185	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MTOR—kidney cancer	3.07e-05	0.000184	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CD4—kidney cancer	3.06e-05	0.000184	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—PIK3CA—kidney cancer	3.05e-05	0.000183	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KDR—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTT1—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ACHE—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MTOR—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PPAT—kidney cancer	3.04e-05	0.000183	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—KRAS—kidney cancer	3.02e-05	0.000181	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PGK1—kidney cancer	2.98e-05	0.000179	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.98e-05	0.000179	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—HIF1A—kidney cancer	2.96e-05	0.000178	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TSC2—kidney cancer	2.95e-05	0.000177	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—PIK3CA—kidney cancer	2.94e-05	0.000177	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—LDHB—kidney cancer	2.93e-05	0.000176	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—KRAS—kidney cancer	2.9e-05	0.000175	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SCARB1—kidney cancer	2.88e-05	0.000173	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CDKN1B—kidney cancer	2.88e-05	0.000173	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CDKN1B—kidney cancer	2.85e-05	0.000171	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS1—kidney cancer	2.85e-05	0.000171	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	2.85e-05	0.000171	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—RAF1—kidney cancer	2.83e-05	0.00017	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KDR—kidney cancer	2.83e-05	0.00017	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—APRT—kidney cancer	2.82e-05	0.00017	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—FH—kidney cancer	2.82e-05	0.00017	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—RELA—kidney cancer	2.82e-05	0.000169	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KIT—kidney cancer	2.8e-05	0.000168	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—APC—kidney cancer	2.8e-05	0.000168	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ERBB2—kidney cancer	2.8e-05	0.000168	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PSMD7—kidney cancer	2.8e-05	0.000168	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL2—kidney cancer	2.79e-05	0.000168	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—PIK3CA—kidney cancer	2.77e-05	0.000167	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MTOR—kidney cancer	2.76e-05	0.000166	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—RAF1—kidney cancer	2.75e-05	0.000165	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—RELA—kidney cancer	2.74e-05	0.000165	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CCND1—kidney cancer	2.72e-05	0.000164	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ERBB2—kidney cancer	2.72e-05	0.000164	CbGpPWpGaD
Aminophylline—HDAC2—Disease—CTNNB1—kidney cancer	2.72e-05	0.000163	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—JUN—kidney cancer	2.72e-05	0.000163	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—CTNNB1—kidney cancer	2.7e-05	0.000162	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MTOR—kidney cancer	2.69e-05	0.000161	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—PIK3CA—kidney cancer	2.67e-05	0.00016	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—POMC—kidney cancer	2.67e-05	0.00016	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GPC3—kidney cancer	2.66e-05	0.00016	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTEN—kidney cancer	2.65e-05	0.000159	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—BCHE—kidney cancer	2.65e-05	0.000159	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RAF1—kidney cancer	2.65e-05	0.000159	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RELA—kidney cancer	2.64e-05	0.000158	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—BRAF—kidney cancer	2.63e-05	0.000158	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PTEN—kidney cancer	2.63e-05	0.000158	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ERBB2—kidney cancer	2.62e-05	0.000157	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.62e-05	0.000157	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KIT—kidney cancer	2.61e-05	0.000157	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—APC—kidney cancer	2.61e-05	0.000157	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	2.59e-05	0.000156	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MTOR—kidney cancer	2.59e-05	0.000155	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA2—kidney cancer	2.58e-05	0.000155	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CA9—kidney cancer	2.54e-05	0.000152	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL2—kidney cancer	2.54e-05	0.000152	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.53e-05	0.000152	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CDKN1B—kidney cancer	2.52e-05	0.000151	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALAD—kidney cancer	2.52e-05	0.000151	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—MAPK3—kidney cancer	2.5e-05	0.00015	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—POMC—kidney cancer	2.48e-05	0.000149	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.48e-05	0.000149	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CCND1—kidney cancer	2.47e-05	0.000149	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL2—kidney cancer	2.47e-05	0.000148	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—JUN—kidney cancer	2.47e-05	0.000148	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.46e-05	0.000148	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—BRAF—kidney cancer	2.45e-05	0.000147	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	2.45e-05	0.000147	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MAPK3—kidney cancer	2.44e-05	0.000147	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CDKN1B—kidney cancer	2.43e-05	0.000146	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CCND1—kidney cancer	2.41e-05	0.000144	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.4e-05	0.000144	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—JUN—kidney cancer	2.4e-05	0.000144	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PTEN—kidney cancer	2.39e-05	0.000143	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—CTNNB1—kidney cancer	2.38e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL2—kidney cancer	2.37e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—MAPK1—kidney cancer	2.37e-05	0.000143	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—VEGFA—kidney cancer	2.37e-05	0.000143	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—MYC—kidney cancer	2.37e-05	0.000143	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PTEN—kidney cancer	2.32e-05	0.000139	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CCND1—kidney cancer	2.32e-05	0.000139	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—JUN—kidney cancer	2.31e-05	0.000139	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.3e-05	0.000138	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PGK1—kidney cancer	2.3e-05	0.000138	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—CTNNB1—kidney cancer	2.29e-05	0.000138	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.27e-05	0.000136	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MAPK3—kidney cancer	2.26e-05	0.000136	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—LDHB—kidney cancer	2.26e-05	0.000136	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK3—kidney cancer	2.25e-05	0.000135	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—KRAS—kidney cancer	2.24e-05	0.000135	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PTEN—kidney cancer	2.23e-05	0.000134	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MYC—kidney cancer	2.2e-05	0.000132	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RAF1—kidney cancer	2.2e-05	0.000132	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RELA—kidney cancer	2.19e-05	0.000132	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MYC—kidney cancer	2.18e-05	0.000131	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ERBB2—kidney cancer	2.18e-05	0.000131	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CRABP1—kidney cancer	2.16e-05	0.00013	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—VEGFA—kidney cancer	2.16e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MAPK1—kidney cancer	2.15e-05	0.000129	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MTOR—kidney cancer	2.15e-05	0.000129	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MAPK1—kidney cancer	2.14e-05	0.000128	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTP1—kidney cancer	2.11e-05	0.000127	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—VEGFA—kidney cancer	2.1e-05	0.000126	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.06e-05	0.000124	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RAF1—kidney cancer	2.05e-05	0.000123	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK3—kidney cancer	2.04e-05	0.000123	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RELA—kidney cancer	2.04e-05	0.000122	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KRAS—kidney cancer	2.04e-05	0.000122	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ERBB2—kidney cancer	2.02e-05	0.000122	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—VEGFA—kidney cancer	2.02e-05	0.000121	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KRAS—kidney cancer	2.02e-05	0.000121	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CDKN1B—kidney cancer	2.02e-05	0.000121	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ITPR2—kidney cancer	2.01e-05	0.00012	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MTOR—kidney cancer	2e-05	0.00012	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ABCB1—kidney cancer	2e-05	0.00012	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK3—kidney cancer	1.98e-05	0.000119	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MYC—kidney cancer	1.98e-05	0.000119	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL2—kidney cancer	1.97e-05	0.000118	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CA9—kidney cancer	1.96e-05	0.000118	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MAPK1—kidney cancer	1.94e-05	0.000117	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTM1—kidney cancer	1.94e-05	0.000116	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MYC—kidney cancer	1.93e-05	0.000116	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CCND1—kidney cancer	1.92e-05	0.000116	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JUN—kidney cancer	1.92e-05	0.000115	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK3—kidney cancer	1.91e-05	0.000115	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—CTNNB1—kidney cancer	1.9e-05	0.000114	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MAPK1—kidney cancer	1.89e-05	0.000113	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CDKN1B—kidney cancer	1.87e-05	0.000113	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PIK3CA—kidney cancer	1.87e-05	0.000112	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MYC—kidney cancer	1.86e-05	0.000112	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PTEN—kidney cancer	1.86e-05	0.000111	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—PIK3CA—kidney cancer	1.85e-05	0.000111	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.85e-05	0.000111	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.84e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL2—kidney cancer	1.83e-05	0.00011	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KRAS—kidney cancer	1.83e-05	0.00011	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTT1—kidney cancer	1.83e-05	0.00011	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ACHE—kidney cancer	1.83e-05	0.00011	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MAPK1—kidney cancer	1.82e-05	0.000109	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—kidney cancer	1.79e-05	0.000108	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CCND1—kidney cancer	1.79e-05	0.000107	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JUN—kidney cancer	1.78e-05	0.000107	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KRAS—kidney cancer	1.78e-05	0.000107	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—CTNNB1—kidney cancer	1.77e-05	0.000106	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SCARB1—kidney cancer	1.73e-05	0.000104	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PTEN—kidney cancer	1.73e-05	0.000104	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KRAS—kidney cancer	1.72e-05	0.000103	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS1—kidney cancer	1.71e-05	0.000103	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	1.68e-05	0.000101	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PSMD7—kidney cancer	1.68e-05	0.000101	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—VEGFA—kidney cancer	1.68e-05	0.000101	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CRABP1—kidney cancer	1.66e-05	0.0001	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—PIK3CA—kidney cancer	1.64e-05	9.84e-05	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—kidney cancer	1.63e-05	9.78e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—BCHE—kidney cancer	1.59e-05	9.57e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK3—kidney cancer	1.59e-05	9.53e-05	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—kidney cancer	1.58e-05	9.52e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—PIK3CA—kidney cancer	1.58e-05	9.47e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.57e-05	9.45e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—VEGFA—kidney cancer	1.56e-05	9.36e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ITPR2—kidney cancer	1.55e-05	9.3e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MYC—kidney cancer	1.54e-05	9.27e-05	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—kidney cancer	1.53e-05	9.16e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.52e-05	9.13e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MAPK1—kidney cancer	1.51e-05	9.06e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.47e-05	8.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK3—kidney cancer	1.47e-05	8.86e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MYC—kidney cancer	1.43e-05	8.61e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KRAS—kidney cancer	1.43e-05	8.56e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTT1—kidney cancer	1.41e-05	8.48e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ACHE—kidney cancer	1.41e-05	8.48e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MAPK1—kidney cancer	1.4e-05	8.43e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—POMC—kidney cancer	1.37e-05	8.23e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SCARB1—kidney cancer	1.34e-05	8.03e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KRAS—kidney cancer	1.32e-05	7.96e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS1—kidney cancer	1.32e-05	7.94e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—PIK3CA—kidney cancer	1.31e-05	7.87e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PSMD7—kidney cancer	1.3e-05	7.79e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.29e-05	7.73e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTP1—kidney cancer	1.27e-05	7.61e-05	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—kidney cancer	1.27e-05	7.61e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—BCHE—kidney cancer	1.23e-05	7.39e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—PIK3CA—kidney cancer	1.22e-05	7.31e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.21e-05	7.3e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ABCB1—kidney cancer	1.2e-05	7.21e-05	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—kidney cancer	1.18e-05	7.07e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.17e-05	7.05e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTM1—kidney cancer	1.16e-05	7e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.1e-05	6.63e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—kidney cancer	1.09e-05	6.56e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTP1—kidney cancer	9.78e-06	5.88e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTEN—kidney cancer	9.53e-06	5.72e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ABCB1—kidney cancer	9.26e-06	5.56e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.07e-06	5.45e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTM1—kidney cancer	8.99e-06	5.4e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.52e-06	5.12e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—POMC—kidney cancer	8.23e-06	4.95e-05	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PIK3CA—kidney cancer	6.72e-06	4.04e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—kidney cancer	6.57e-06	3.95e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—POMC—kidney cancer	6.35e-06	3.82e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTEN—kidney cancer	5.73e-06	3.44e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—kidney cancer	5.07e-06	3.04e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTEN—kidney cancer	4.42e-06	2.66e-05	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PIK3CA—kidney cancer	4.04e-06	2.43e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.12e-06	1.87e-05	CbGpPWpGaD
